BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Inflammatory disorder
,
Hypothalamus
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
melanism
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
DUH1
DUH2
SASH1
PSHK2
ABCB6
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
chr6q24
SASH1, SAM domain repeat 2
SASH1, SAM domain repeat 1
SAM and SH3 domain-containing protein 1, SH3 domain
Mitochondrial ABC-transporter, N-terminal five TM domain
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
OMIM - Dyschromatosis universalis
OMIM - Congenital disorder
OMIM - Skin Related Disorders
Explore Curated Studies Results
Literature
Most Relevant Literature
The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MA…
A test of the thermal melanism hypothesis in the wingless grasshopper Phaulacridium vittatum.
The costs of being dark: the genetic basis of melanism and its association with fitness-related trai…
More than a colour change: insect melanism, disease resistance and fecundity.
Genetic and phenotypic relationships between immune defense, melanism and life-history traits at dif…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones
Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma
Melanated Group Midwifery Care (MGMC)
Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma
Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ